Array spins out Yarra to develop ARRY-797

Array BioPharma Inc. (NASDAQ:ARRY) spun out Yarra Therapeutics LLC (Boulder, Colo.) to develop ARRY-797. In 2016, Array reported data from a Phase II trial in patients with symptomatic dilated cardio...